Daejeon, South Korea

Sung Woong Jang

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Lg Chem, Ltd. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sung Woong Jang. Retrieved from https://idiyas.com/inventor/sung-woong-jang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 15.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Sung Woong Jang

Introduction

Sung Woong Jang is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of polypeptides. His work has implications for various medical applications, showcasing the importance of innovation in healthcare.

Latest Patents

Sung Woong Jang holds a patent for a "Polypeptide Specific for Mucin 1 and Use Thereof." This invention highlights his expertise in creating specific polypeptides that can be utilized in therapeutic contexts, potentially improving treatment options for diseases related to mucin 1.

Career Highlights

Jang is currently employed at LG Chem, Ltd., a leading chemical company known for its advancements in various sectors, including biotechnology. His role at LG Chem allows him to leverage his skills and knowledge to drive innovation within the company.

Collaborations

Sung Woong Jang collaborates with Hae Youn Lee, another professional in the field. Their partnership exemplifies the collaborative nature of scientific research and innovation, as they work together to advance their projects.

Conclusion

Sung Woong Jang's contributions to biotechnology through his patent and work at LG Chem, Ltd. demonstrate the vital role of inventors in advancing medical science. His innovative spirit continues to inspire future developments in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…